The ocular surface epithelial barrier and other mechanisms of mucosal protection: from allergy to infectious diseases

Current Opinion in Allergy and Clinical Immunology

Volumn 13, Issue 5, 2013, Pages 563-568

  Mantelli, Flavio ^a   Mauris, Jerome ^b   Argüeso, Pablo ^b  

^a IRCCS Fodazione G B Bietti of Rome   (Italy)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Epithelial barrier; Galectin 3,; Glycocalyx; Ocular surface; Transmembrane mucin

Indexed keywords

MUCIN; MUCIN 1; MUCIN 16; MUCIN 4; UNCLASSIFIED DRUG;

ALLERGIC CONJUNCTIVITIS; ALLERGIC REACTION; ALLERGY; ANDROGEN INSENSITIVITY SYNDROME; CELL COMMUNICATION; CELL DIFFERENTIATION; CORNEA EPITHELIUM; DESICCATION; DRY EYE; EYE DISEASE; GLYCOCALYX; HUMAN; KERATITIS; KERATOPATHY; NONHUMAN; OCULAR SURFACE DISEASE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTECTION; PTERYGIUM; REVIEW;

ANIMALS; CONJUNCTIVA; EPITHELIUM, CORNEAL; EYE; EYE DISEASES; GLYCOCALYX; HOMEOSTASIS; HUMANS; HYPERSENSITIVITY; IMMUNITY, MUCOSAL; INFECTION; MUCINS; TIGHT JUNCTIONS;

EID: 84883600340     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3283645899     Document Type: Review

References (63)

1. Childers NK, Bruce MG, McGhee Jr. Molecular mechanisms of immunoglobulin A defense. Annu Rev Microbiol 1989; 43:503-536.
2. Kesimer M, Ehre C, Burns KA, et al. Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways. Mucosal Immunol 2013; 6:379-392.
3. Suzuki K, Saito J, Yanai R, et al. Cell-matrix and cell-cell interactions during corneal epithelial wound healing. Prog Retin Eye Res 2003; 22: 113-133.
4. Ban Y, Dota A, Cooper LJ, et al. Tight junction-related protein expression and distribution in human corneal epithelium. Exp Eye Res 2003; 76:663-669.
5. Denker BM, Nigam SK. Molecular structure and assembly of the tight junction. Am J Physiol 1998; 274:F1-F9.
6. Sugrue SP, Zieske JD. ZO1 in corneal epithelium: Association to the zonula occludens and adherens junctions. Exp Eye Res 1997; 64:11-20.
7. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001; 2:285-293.
8. Kumar NM, Gilula NB. The gap junction communication channel. Cell 1996; 84:381-388.
9. Swamynathan S, Kenchegowda D, Piatigorsky J. Regulation of corneal epithelial barrier function by Kruppel-like transcription factor 4. Invest Ophthalmol Vis Sci 2011; 52:1762-1769.
10. Mantelli F, Argueso P. Functions of ocular surface mucins in health and disease. Curr Opin Allergy Clin Immunol 2008; 8:477-483.
11. Blalock TD, Spurr-Michaud SJ, Tisdale AS, et al. Functions of MUC16 in corneal epithelial cells. Invest Ophthalmol Vis Sci 2007; 48:4509-4518.
12. Argueso P, Guzman-Aranguez A, Mantelli F, et al. Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier. J Biol Chem 2009; 284:23037-23045.
13. Ahmad N, Gabius HJ, Andre S, et al. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous crosslinked complexes. J Biol Chem 2004; 279:10841-10847.
14. Mantelli F, Schaffer L, Dana R, et al. Glycogene expression in conjunctiva of patients with dry eye: Downregulation of Notch signaling. Invest Ophthalmol Vis Sci 2009; 50:2666-2672.
15. Hodges MG, Keane-Myers AM. Classification of ocular allergy. Curr Opin Allergy Clin Immunol 2007; 7:424-428.
16. Mantelli F, Lambiase A, Bonini S. Clinical trials in allergic conjunctivits: A systematic review. Allergy 2011; 66:919-924.
17. Mattila P, Joenvaara S, Renkonen J, et al. Allergy as an epithelial barrier disease. Clin Translat Allergy 2011; 1:5.
18. Xiao C, Puddicombe SM, Field S, et al. Defective epithelial barrier function in asthma. J Allergy Clin Immunol 2011; 128:549-556.
19. Yokoi K, Yokoi N, Kinoshita S. Impairment of ocular surface epithelium barrier function in patients with atopic dermatitis. Br J Ophthalmol 1998; 82:797-800.
20. Kunert KS, Keane-Myers AM, Spurr-Michaud S, et al. Alteration in goblet cell numbers and mucin gene expression in a mouse model of allergic conjunctivitis. Invest Ophthalmol Vis Sci 2001; 42:2483-2489.
21. Dogru M, Matsumoto Y, Okada N, et al. Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis. Allergy 2008; 63:1324-1334.
22. Dogru M, Okada N, Asano-Kato N, et al. Alterations of the ocular surface epithelial mucins 1, 2, 4 and the tear functions in patients with atopic keratoconjunctivitis. Clin Exp Allergy 2006; 36:1556-1565.
23. Dogru M, Okada N, Asano-Kato N, et al. Atopic ocular surface disease: Implications on tear function and ocular surface mucins. Cornea 2005; 24:S18-S23.
24. van den Berg TK, Honing H, Franke N, et al. LacdiNAc-glycans constitute a parasite pattern for galectin-3-mediated immune recognition. J Immunol 2004; 173:1902-1907.
25. van Die I, Cummings RD. Glycans modulate immune responses in helminth infections and allergy. Chem Immunol Allergy 2006; 90:91-112.
26. Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol 2008; 8:205-217.
27. McClellan KA. Mucosal defense of the outer eye. Surv Ophthalmol 1997; 42:233-246.
28. Fleiszig SM, Zaidi TS, Ramphal R, Pier GB. Modulation of Pseudomonas aeruginosa adherence to the corneal surface by mucus. Infect Immun 1994; 62:1799-1804.
29. Kardon R, Price RE, Julian J, et al. Bacterial conjunctivitis in Muc1 null mice. Invest Ophthalmol Vis Sci 1999; 40:1328-1335.
30. Danjo Y, Hazlett LD, Gipson IK. C57BL/6 mice lacking Muc1 show no ocular surface phenotype. Invest Ophthalmol Vis Sci 2000; 41:4080-4084.
31. Ricciuto J, Heimer SR, Gilmore MS, Argueso P. Cell surface O-glycans limit Staphylococcus aureus adherence to corneal epithelial cells. Infect Immun 2008; 76:5215-5220.
32. Govindarajan B, Menon BB, Spurr-Michaud S, et al. A metalloproteinase secreted by Streptococcus pneumoniae removes membrane mucin MUC16 from the epithelial glycocalyx barrier. PLoS One 2012; 7:e32418.
33. Vasta GR. Roles of galectins in infection. Nat Rev Microbiol 2009; 7:424-438.
34. Woodward AM, Mauris J, Argueso P. Binding of transmembrane mucins to galectin-3 limits herpesvirus 1 infection of human corneal keratinocytes. J Virol 2013; 87:5841-5847.
35. Cao Z, Said N, Amin S, et al. Galectins-3 and -7, but not galectin-1, play a role in re-epithelialization of wounds. J Biol Chem 2002; 277:42299-42305.
36. Gipson IK, Riddle CV, Kiorpes TC, Spurr SJ. Lectin binding to cell surfaces: Comparisons between normal and migrating corneal epithelium. Dev Biol 1983; 96:337-345.
37. McLaughlin BJ, Barlar EK, Donaldson DJ. Wheat germ agglutinin and concanavalin A binding during epithelial wound healing in the cornea. Curr Eye Res 1986; 5:601-609.
38. Gupta SK, Masinick S, Garrett M, Hazlett LD. Pseudomonas aeruginosa lipopolysaccharide binds galectin-3 and other human corneal epithelial proteins. Infect Immun 1997; 65:2747-2753.
39. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003; 136:318-326.
40. Danjo Y, Watanabe H, Tisdale AS, et al. Alteration of mucin in human conjunctival epithelia in dry eye. Invest Ophthalmol Vis Sci 1998; 39: 2602-2609.
41. Hayashi Y, Kao WW, Kohno N, et al. Expression patterns of sialylated epitope recognized by KL-6 monoclonal antibody in ocular surface epithelium of normals and dry eye patients. Invest Ophthalmol Vis Sci 2004; 45:2212-2217.
42. Koufakis DI, Karabatsas CH, Sakkas LI, et al. Conjunctival surface changes in patients with Sjogren's syndrome: A transmission electron microscopy study. Invest Ophthalmol Vis Sci 2006; 47:541-544.
43. Pflugfelder SC, Tseng SC, Yoshino K, et al. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation. Ophthalmology 1997; 104:223-235.
44. Argueso P, Tisdale A, Mandel U, et al. The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization. Invest Ophthalmol Vis Sci 2003; 44:86-92.
45. Xiong L, Woodward AM, Argueso P. Notch signaling modulates MUC16 biosynthesis in an in vitro model of human corneal and conjunctival epithelial cell differentiation. Invest Ophthalmol Vis Sci 2011; 52:5641-5646.
46. Glasgow BJ, Gasymov OK, Casey RC. Exfoliative epitheliopathy of bullous keratopathy with breaches in the MUC16 Glycocalyx. Invest Ophthalmol Vis Sci 2009; 50:4060-4064.
47. Mantelli F, Moretti C, Micera A, Bonini S. Conjunctival mucin deficiency in complete androgen insensitivity syndrome (CAIS). Graefes Arch Clin Exp Ophthalmol 2007; 245:899-902.
48. Kase S, Kitaichi N, Furudate N, et al. Increased expression of mucinous glycoprotein KL-6 in human pterygium. Br J Ophthalmol 2006; 90:1208-1209.
49. Schlotzer-Schrehardt U, Andre S, Janko C, et al. Adhesion/growth- regulatory galectins in the human eye: Localization profiles and tissue reactivities as a standard to detect disease-associated alterations. Graefes Arch Clin Exp Ophthalmol 2012; 250:1169-1180.
50. Hrdlickova-Cela E, Plzak J, Smetana K, et al. Detection of galectin-3 in tear fluid at disease states and immunohistochemical and lectin histochemical analysis in human corneal and conjunctival epithelium. Br J Ophthalmol 2001; 85:1336-1340.
51. Ehrhardt C. Drug absorption studies: In situ, in vitro and in silico models. New York: Springer; 2008.
52. Geroski DH, Edelhauser HF. Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci 2000; 41:961-964.
53. Kompella UB, Kadam RS, Lee VH. Recent advances in ophthalmic drug delivery. Ther Deliv 2010; 1:435-456.
54. Khutoryanskiy VV. Advances in mucoadhesion and mucoadhesive polymers. Macromol Biosci 2011; 11:748-764.
55. Bravo-Osuna I, Noiray M, Briand E, et al. Interfacial interaction between transmembrane ocular mucins and adhesive polymers and dendrimers analyzed by surface plasmon resonance. Pharm Res 2012; 29:2329-2340.
56. Woodward AM, Senchyna M, Williams R, Argueso P. Characterization of the interaction between hydroxypropyl guar galactomannan and galectin-3. Biochem Biophys Res Commun 2012; 424:12-17.
57. Kaur IP, Smitha R. Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm 2002; 28:353-369.
58. Di Colo G, Zambito Y, Zaino C. Polymeric enhancers of mucosal epithelia permeability: Synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues. J Pharm Sci 2008; 97:1652-1680.
59. Sasaki H, Yamamura K, Mukai T, et al. Enhancement of ocular drug penetration. Crit Rev Ther Drug Carrier Syst 1999; 16:85-146.
60. Okabe K, Kimura H, Okabe J, et al. Effect of benzalkonium chloride on transscleral drug delivery. Invest Ophthalmol Vis Sci 2005; 46:703-708.
61. Kaur IP, Lal S, Rana C, et al. Ocular preservatives: Associated risks and newer options. Cutan Ocul Toxicol 2009; 28:93-103.
62. Sacchetti M, Lambiase A, Coassin M, Bonini S. Toxic corneal ulcer: A frequent and sight-threatening disease. Eur J Ophthalmol 2009; 19:916-922.
63. Kazmierczak BI, Mostov K, Engel JN. Interaction of bacterial pathogens with polarized epithelium. Annu Rev Microbiol 2001; 55:407-435.